• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测肺癌、结肠癌和乳腺癌预后的代谢相关基因风险模型的识别与验证

Identification and validation of a metabolic-related gene risk model predicting the prognosis of lung, colon, and breast cancers.

作者信息

Khan Jiyauddin, Bareja Chanchal, Dwivedi Kountay, Mathur Ankit, Kumar Naveen, Saluja Daman

机构信息

Dr B R Ambedkar Center for Biomedical Research, University of Delhi, Delhi, 110007, India.

Department of Computer Science, FacultyofMathematicalSciences, University of Delhi, Delhi, 110007, India.

出版信息

Sci Rep. 2025 Jan 8;15(1):1374. doi: 10.1038/s41598-025-85366-8.

DOI:10.1038/s41598-025-85366-8
PMID:39779736
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11711664/
Abstract

Metabolic reprogramming, vital for cancer cells to adapt to the altered microenvironment, remains a topic requiring further investigation for different tumor types. Our study aims to elucidate shared metabolic reprogramming across breast (BRC), colorectal (CRC), and lung (LUC) cancers. Leveraging gene expression data from the Gene Expression Omnibus and various bioinformatics tools like MSigDB, WebGestalt, String, and Cytoscape, we identified key/hub metabolism-related genes (MRGs) and their interactions. The functional characteristics including survival parameters and expression of the key MRGs were analyzed and validated through Gene Expression Profiling Interactive Analysis 2 and qRT-PCR. In addition, we employed machine learning algorithms such as k-nearest neighbours (KNN), support vector regressor (SVR), and extreme gradient boosting (XGBoost) to assess MRGs' effectiveness in predicting overall patient survival. Among 11,384 DEGs analyzed, 540 overlapped across BRC, CRC, and LUC, with 46 MRGs and 20 key/hub MRGs involved in all studied cancer types. Of these, 11 key MRGs were prognostically significant. The qRT-PCR validation of key MRGs in specific cancer cell lines confirmed their expression profiles, with some showing cell-type-specific patterns. SVR exhibited remarkable accuracy in predicting overall survival, emphasizing its clinical utility. Our integrated approach combining bioinformatics analyses and experimental validations underscores the potential of MRGs as biomarkers for metabolic therapies, with machine learning models enhancing predictive capabilities for patient outcomes.

摘要

代谢重编程对于癌细胞适应改变的微环境至关重要,仍然是不同肿瘤类型中需要进一步研究的课题。我们的研究旨在阐明乳腺癌(BRC)、结直肠癌(CRC)和肺癌(LUC)之间共享的代谢重编程。利用来自基因表达综合数据库(Gene Expression Omnibus)的基因表达数据以及诸如MSigDB、WebGestalt、String和Cytoscape等各种生物信息学工具,我们确定了关键/核心代谢相关基因(MRG)及其相互作用。通过基因表达谱交互式分析2(Gene Expression Profiling Interactive Analysis 2)和qRT-PCR分析并验证了关键MRG的功能特征,包括生存参数和表达情况。此外,我们采用了诸如k近邻算法(KNN)、支持向量回归(SVR)和极端梯度提升(XGBoost)等机器学习算法来评估MRG在预测患者总体生存方面的有效性。在分析的11384个差异表达基因(DEG)中,有540个在BRC、CRC和LUC中重叠,其中46个MRG和20个关键/核心MRG涉及所有研究的癌症类型。其中,11个关键MRG具有预后意义。在特定癌细胞系中对关键MRG进行的qRT-PCR验证证实了它们的表达谱,有些显示出细胞类型特异性模式。SVR在预测总体生存方面表现出显著的准确性,强调了其临床实用性。我们将生物信息学分析与实验验证相结合的综合方法强调了MRG作为代谢疗法生物标志物的潜力,机器学习模型增强了对患者预后的预测能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bf7/11711664/b81e2df1cb53/41598_2025_85366_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bf7/11711664/cc4c7d16bf91/41598_2025_85366_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bf7/11711664/2f925c00dd2c/41598_2025_85366_Fig2a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bf7/11711664/2ed460399757/41598_2025_85366_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bf7/11711664/bf6b3ac4399b/41598_2025_85366_Fig4a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bf7/11711664/17c26e387896/41598_2025_85366_Fig5a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bf7/11711664/ed66a813a8f9/41598_2025_85366_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bf7/11711664/b81e2df1cb53/41598_2025_85366_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bf7/11711664/cc4c7d16bf91/41598_2025_85366_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bf7/11711664/2f925c00dd2c/41598_2025_85366_Fig2a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bf7/11711664/2ed460399757/41598_2025_85366_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bf7/11711664/bf6b3ac4399b/41598_2025_85366_Fig4a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bf7/11711664/17c26e387896/41598_2025_85366_Fig5a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bf7/11711664/ed66a813a8f9/41598_2025_85366_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bf7/11711664/b81e2df1cb53/41598_2025_85366_Fig7_HTML.jpg

相似文献

1
Identification and validation of a metabolic-related gene risk model predicting the prognosis of lung, colon, and breast cancers.预测肺癌、结肠癌和乳腺癌预后的代谢相关基因风险模型的识别与验证
Sci Rep. 2025 Jan 8;15(1):1374. doi: 10.1038/s41598-025-85366-8.
2
Mitochondrial-related genes as prognostic and metastatic markers in breast cancer: insights from comprehensive analysis and clinical models.线粒体相关基因作为乳腺癌的预后和转移标志物:综合分析和临床模型的见解。
Front Immunol. 2024 Sep 24;15:1461489. doi: 10.3389/fimmu.2024.1461489. eCollection 2024.
3
A Computational Recognition Analysis of Promising Prognostic Biomarkers in Breast, Colon and Lung Cancer Patients.乳腺癌、结肠癌和肺癌患者中有前景的预后生物标志物的计算识别分析
Int J Mol Sci. 2025 Jan 25;26(3):1017. doi: 10.3390/ijms26031017.
4
Differential gene expression analysis and machine learning identified structural, TFs, cytokine and glycoproteins, including SOX2, TOP2A, SPP1, COL1A1, and TIMP1 as potential drivers of lung cancer.差异基因表达分析和机器学习确定了结构蛋白、转录因子、细胞因子和糖蛋白,包括SOX2、TOP2A、SPP1、COL1A1和TIMP1作为肺癌的潜在驱动因素。
Biomarkers. 2025 Mar;30(2):200-215. doi: 10.1080/1354750X.2025.2461698. Epub 2025 Feb 10.
5
The role and machine learning analysis of mitochondrial autophagy-related gene expression in lung adenocarcinoma.线粒体自噬相关基因表达在肺腺癌中的作用及机器学习分析
Front Immunol. 2025 Apr 17;16:1509315. doi: 10.3389/fimmu.2025.1509315. eCollection 2025.
6
Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.通过综合生物信息学分析鉴定和验证非小细胞肺癌中具有预后价值的关键基因。
Thorac Cancer. 2020 Apr;11(4):851-866. doi: 10.1111/1759-7714.13298. Epub 2020 Feb 14.
7
SPDYC serves as a prognostic biomarker related to lipid metabolism and the immune microenvironment in breast cancer.SPDYC 可作为与乳腺癌脂质代谢和免疫微环境相关的预后生物标志物。
Immunol Res. 2024 Oct;72(5):1030-1050. doi: 10.1007/s12026-024-09505-5. Epub 2024 Jun 18.
8
Identification of potential biomarkers with colorectal cancer based on bioinformatics analysis and machine learning.基于生物信息学分析和机器学习的结直肠癌潜在生物标志物的鉴定。
Math Biosci Eng. 2021 Oct 19;18(6):8997-9015. doi: 10.3934/mbe.2021443.
9
Identification and clinicopathological analysis of potential p73-regulated biomarkers in colorectal cancer via integrative bioinformatics.基于整合生物信息学的方法鉴定和临床病理分析结直肠癌中潜在的 p73 调控生物标志物
Sci Rep. 2024 Apr 30;14(1):9894. doi: 10.1038/s41598-024-60715-1.
10
Integrative bioinformatics and machine learning identify key crosstalk genes and immune interactions in head and neck cancer and Hodgkin lymphoma.整合生物信息学和机器学习识别头颈癌和霍奇金淋巴瘤中的关键串扰基因和免疫相互作用。
Sci Rep. 2025 May 6;15(1):15745. doi: 10.1038/s41598-025-99017-5.

本文引用的文献

1
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
2
PDK4-dependent hypercatabolism and lactate production of senescent cells promotes cancer malignancy.衰老细胞中 PDK4 依赖性的过度分解代谢和乳酸生成促进了癌症的恶性程度。
Nat Metab. 2023 Nov;5(11):1887-1910. doi: 10.1038/s42255-023-00912-w. Epub 2023 Oct 30.
3
PFKP is a prospective prognostic, diagnostic, immunological and drug sensitivity predictor across pan-cancer.
PFKP 是一种跨癌症的前瞻性预后、诊断、免疫和药物敏感性预测因子。
Sci Rep. 2023 Oct 13;13(1):17399. doi: 10.1038/s41598-023-43982-2.
4
PFKP: More than phosphofructokinase.PFKP:不止是磷酸果糖激酶。
Adv Cancer Res. 2023;160:1-15. doi: 10.1016/bs.acr.2023.03.001. Epub 2023 Mar 30.
5
Ribonucleotide reductase M2 (RRM2): Regulation, function and targeting strategy in human cancer.核糖核苷酸还原酶M2(RRM2):人类癌症中的调控、功能及靶向策略
Genes Dis. 2022 Dec 28;11(1):218-233. doi: 10.1016/j.gendis.2022.11.022. eCollection 2024 Jan.
6
Aurora kinase A/AURKA functionally interacts with the mitochondrial ATP synthase to regulate energy metabolism and cell death.极光激酶A/AURKA与线粒体ATP合酶在功能上相互作用,以调节能量代谢和细胞死亡。
Cell Death Discov. 2023 Jun 29;9(1):203. doi: 10.1038/s41420-023-01501-2.
7
A functional genetic screen for metabolic proteins unveils GART and the purine biosynthetic pathway as novel targets for the treatment of luminal A ERα expressing primary and metastatic invasive ductal carcinoma.一项代谢蛋白的功能遗传筛选揭示了 GART 和嘌呤生物合成途径是治疗腔 A ERα 表达的原发性和转移性浸润性导管癌的新靶点。
Front Endocrinol (Lausanne). 2023 Apr 18;14:1129162. doi: 10.3389/fendo.2023.1129162. eCollection 2023.
8
Metabolic reprogramming in cancer: Mechanisms and therapeutics.癌症中的代谢重编程:机制与治疗方法。
MedComm (2020). 2023 Mar 27;4(2):e218. doi: 10.1002/mco2.218. eCollection 2023 Apr.
9
Nucleotide metabolism: a pan-cancer metabolic dependency.核苷酸代谢:一种泛癌代谢依赖性。
Nat Rev Cancer. 2023 May;23(5):275-294. doi: 10.1038/s41568-023-00557-7. Epub 2023 Mar 27.
10
The Gene Ontology knowledgebase in 2023.2023 版基因本体论知识库。
Genetics. 2023 May 4;224(1). doi: 10.1093/genetics/iyad031.